Jefferies Starts Watson Pharmaceuticals (WPI) at Hold

Jefferies initiates coverage on Watson Pharmaceuticals (NYSE: WPI) with a Hold. PT $70.00.

The firm comments, "While we find Watson's fundamentals compelling, the valuation seems to reflect that. We're concerned that 2013 consensus EPS ($6.22) assumes a best case scenario for generic launches that are not yet certain and is too low for R&D spend. But given the excitement around Lipitor, Concerta, and Procheive we also don't see the stock underperforming in the near-term."

For an analyst ratings summary and ratings history on Watson Pharmaceuticals click here. For more ratings news on Watson Pharmaceuticals click here.

Shares of Watson Pharmaceuticals closed at $64.62 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Resumes York Space Systems (YSS) at Buy Following ALL.SPACE Acquisition
• Berenberg Starts Alm Brand A/S (ALMB:DC) at Hold
• Jefferies Upgrades Shopify (SHOP) to Buy